from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1040c/PE8

LFCtreatmentdescriptionclass of inhibitor

0.069

Amikacinug/mL Amikacintranslation

0.441

Cap5-10ug/mL Capreomycintranslation

0.476

Rox10-50 ug/mL Roxithromycintranslation

0.784

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.338

Rif0.2-5ug/mL Rifampicintranscription

-0.147

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.037

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.034

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.073

CPZ10-50 ug/mL Chlorpromazinerespiration

0.421

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.145

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.487

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.607

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.385

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.117

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.184

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.410

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.235

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.295

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.298

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.604

Nigericin50 uM Nigericinrespiration

0.210

TRC10-150 ug/mL Triclosanrespiration

0.096

TRZ10-25 ug/mL Thioridazinerespiration

0.929

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.891

menadione6-10 ug/mL Menadionerespiration

0.249

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.370

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.170

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.054

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.923

NRP_1Non-replicating persistence stage 1dosRassociated

0.291

Amp0.2mg/mL AmpicillincellWall

0.544

Cephalexin20-100 ug/mL CephalexincellWall

1.421

Cerulenin0.32-5 ug/mL CerulenincellWall

0.405

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.180

EMB10-20 ug/mL EthambutolcellWall

0.499

Eta12-40 ug/mL EthionamidecellWall

0.387

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.317

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.122

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.318

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.104

BZA0.12 mg/mL BenzamidearomaticAmides

-1.314

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.890

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.364

H2O24 mM hydrogen peroxideDNAdamaging

-0.136

Levo10 ug/mL LevofloxacinDNAdamaging

-0.516

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.780

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.065

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.420

UVUV-irradiationDNAdamaging

-0.438

ARP41-4 ug/mL Antitubercular compound ARP4?

0.542

Antimycin12.5-50 ug/mL Antimycin A?

-1.324

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.399

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.026

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.464

PA8240.2-2 ug/mL PA-824?

0.011

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.331

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.767

Verapamil50 uM Verapamil?

-1.384

mercaptoethanol2 mM 2-Mercaptoethanol?

0.516

methoxatin10-20 ug/mL Methoxatin?